NCT05941676View on ClinicalTrials.gov

Prognostic Immune Biomarkers in HNSCC

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

August 30, 2022

Study Completion Date

June 30, 2023

Conditions
Head and Neck CancerSquamous Cell Carcinoma
Interventions
DIAGNOSTIC_TEST

Tumour immunoprofile evaluation

Tumour immunoprofile evaluation will be performed in patients with head and neck cancer.

Trial Locations (1)

70852

University Hospital Ostrava, Ostrava

All Listed Sponsors
lead

University Hospital Ostrava

OTHER

NCT05941676 - Prognostic Immune Biomarkers in HNSCC | Biotech Hunter | Biotech Hunter